147 related articles for article (PubMed ID: 11051261)
1. Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/ myelodysplastic syndrome and de novo acute myeloid leukemia.
Naoe T; Takeyama K; Yokozawa T; Kiyoi H; Seto M; Uike N; Ino T; Utsunomiya A; Maruta A; Jin-nai I; Kamada N; Kubota Y; Nakamura H; Shimazaki C; Horiike S; Kodera Y; Saito H; Ueda R; Wiemels J; Ohno R
Clin Cancer Res; 2000 Oct; 6(10):4091-5. PubMed ID: 11051261
[TBL] [Abstract][Full Text] [Related]
2. The GST deletions and NQO1*2 polymorphism confers interindividual variability of response to treatment in patients with acute myeloid leukemia.
Barragan E; Collado M; Cervera J; Martin G; Bolufer P; Roman J; Sanz MA
Leuk Res; 2007 Jul; 31(7):947-53. PubMed ID: 17118447
[TBL] [Abstract][Full Text] [Related]
3. The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia.
Bolufer P; Collado M; Barragán E; Cervera J; Calasanz MJ; Colomer D; Roman-Gómez J; Sanz MA
Haematologica; 2007 Mar; 92(3):308-14. PubMed ID: 17339179
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia.
Larson RA; Wang Y; Banerjee M; Wiemels J; Hartford C; Le Beau MM; Smith MT
Blood; 1999 Jul; 94(2):803-7. PubMed ID: 10397748
[TBL] [Abstract][Full Text] [Related]
5. Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia.
Bolufer P; Collado M; Barragan E; Calasanz MJ; Colomer D; Tormo M; González M; Brunet S; Batlle M; Cervera J; Sanz MA
Br J Haematol; 2007 Feb; 136(4):590-6. PubMed ID: 17367411
[TBL] [Abstract][Full Text] [Related]
6. Association of CYP3A4 genotype with treatment-related leukemia.
Felix CA; Walker AH; Lange BJ; Williams TM; Winick NJ; Cheung NK; Lovett BD; Nowell PC; Blair IA; Rebbeck TR
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13176-81. PubMed ID: 9789061
[TBL] [Abstract][Full Text] [Related]
7. Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1.
Haase D; Binder C; Bünger J; Fonatsch C; Streubel B; Schnittger S; Griesinger F; Westphal G; Schoch C; Knopp A; Berkovicz D; Krieger O; Wörmann B; Hilgers R; Hallier E; Schulz T
Leuk Res; 2002 Mar; 26(3):249-54. PubMed ID: 11792413
[TBL] [Abstract][Full Text] [Related]
8. MDR-1 and GST polymorphisms are involved in myelodysplasia progression.
Palodetto B; de Melo Campos P; Benites BD; de Lourdes Lopes Ferrari Chauffaille M; Velloso ED; Traina F; Saad ST
Leuk Res; 2013 Aug; 37(8):970-3. PubMed ID: 23684483
[TBL] [Abstract][Full Text] [Related]
9. Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients.
Rund D; Krichevsky S; Bar-Cohen S; Goldschmidt N; Kedmi M; Malik E; Gural A; Shafran-Tikva S; Ben-Neriah S; Ben-Yehuda D
Leukemia; 2005 Nov; 19(11):1919-28. PubMed ID: 16167058
[TBL] [Abstract][Full Text] [Related]
10. The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes.
Fabiani E; Fianchi L; Falconi G; Boncompagni R; Criscuolo M; Guidi F; La Brocca A; Hohaus S; Leone G; Voso MT
Leuk Lymphoma; 2014 Jul; 55(7):1538-43. PubMed ID: 24047476
[TBL] [Abstract][Full Text] [Related]
11. High frequency of NAD(P)H:quinone oxidoreductase 1 (NQO1) C(609)T germline polymorphism in MDS/AML with trisomy 8.
Zachaki S; Stavropoulou C; Koromila T; Manola KN; Kalomoiraki M; Daraki A; Koumbi D; Athanasiadou A; Kanavakis E; Kollia P; Sambani C
Leuk Res; 2013 Jul; 37(7):742-6. PubMed ID: 23643325
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies.
Blanco JG; Edick MJ; Hancock ML; Winick NJ; Dervieux T; Amylon MD; Bash RO; Behm FG; Camitta BM; Pui CH; Raimondi SC; Relling MV
Pharmacogenetics; 2002 Nov; 12(8):605-11. PubMed ID: 12439220
[TBL] [Abstract][Full Text] [Related]
13. Genotype of glutathione S-transferase and other genetic configurations in myelodysplasia.
Sasai Y; Horiike S; Misawa S; Kaneko H; Kobayashi M; Fujii H; Kashima K; Taniwaki M
Leuk Res; 1999 Nov; 23(11):975-81. PubMed ID: 10576500
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia.
Seedhouse C; Faulkner R; Ashraf N; Das-Gupta E; Russell N
Clin Cancer Res; 2004 Apr; 10(8):2675-80. PubMed ID: 15102670
[TBL] [Abstract][Full Text] [Related]
15. Glutathione S-transferase polymorphisms in children with myeloid leukemia: a Children's Cancer Group study.
Davies SM; Robison LL; Buckley JD; Radloff GA; Ross JA; Perentesis JP
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):563-6. PubMed ID: 10868689
[TBL] [Abstract][Full Text] [Related]
16. Association of glutathione S-transferase, EPHX, and p53 codon 72 gene polymorphisms with adult acute myeloid leukemia.
Chauhan PS; Ihsan R; Yadav DS; Mishra AK; Bhushan B; Soni A; Kaushal M; Devi TR; Saluja S; Gupta DK; Mittal V; Saxena S; Kapur S
DNA Cell Biol; 2011 Jan; 30(1):39-46. PubMed ID: 20731606
[TBL] [Abstract][Full Text] [Related]
17. Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.
Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Fu B; Tang G; Goswami M; Singh R; Kanagal-Shamanna R; Pierce SA; Young KH; Kantarjian HM; Medeiros LJ; Luthra R; Wang SA
Leuk Res; 2015 Mar; 39(3):348-54. PubMed ID: 25573287
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes.
Voso MT; Fabiani E; D'Alo' F; Guidi F; Di Ruscio A; Sica S; Pagano L; Greco M; Hohaus S; Leone G
Ann Oncol; 2007 Sep; 18(9):1523-8. PubMed ID: 17761709
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between GSTT1, GSTM1 and NQO1 gene polymorphism and acute myeloid leukemia and recurrent chromosome translocations].
Yang L; Zhang Y; Zhang MR; Xiao ZJ
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(33):2312-6. PubMed ID: 16321221
[TBL] [Abstract][Full Text] [Related]
20. TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases.
Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Peng J; Tang G; Goswami M; Young KH; Singh R; Medeiros LJ; Kantarjian HM; Luthra R; Wang SA
J Hematol Oncol; 2015 May; 8():45. PubMed ID: 25952993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
